VRAX Virax Biolabs Group Limited
$2.67▼ -6.32%
Healthcare
Other
After hours
$2.85▲ +6.74%
Sep 11, 7:54 PM ET
Volume 36.8K
Avg Volume (10D) 41.0K
Key Metrics & Fundamentals
Market Cap
$2.13M
P/E Ratio
–
Div Yield
–%
52W Range
2.50 - 21.75
% vs 50 MA
-14.77%
% vs 200 MA
-50.43%
RSI-14
44.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.19
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution
ACCESS Newswire · Aug 20, 2026 2:00 PM
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Aug 7, 2026 1:00 PM
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESS Newswire · Jul 20, 2026 1:00 PM
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
PR Newswire · Jul 16, 2026 11:30 AM
Virax Biolabs enters immune profiling product supply deal with Fosun
Hospital Management · Jul 13, 2026 9:48 AM
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
PR Newswire · Jul 10, 2026 8:05 PM
Top Midday Decliners
MT Newswires · Jul 10, 2026 6:06 PM
Top Premarket Decliners
MT Newswires · Jul 10, 2026 11:35 AM
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
PR Newswire · Jul 9, 2026 5:35 PM
Why Did Virax Biolabs Stock Triple In One Session?
Benzinga · Jul 9, 2026 2:31 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for VRAX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.